Press release
-
SRI International awarded $11.5 million DARPA contract to accelerate fully homomorphic encryption
A practical fully homomorphic encryption capability could secure data being processed on, and sent to, untrusted clouds
-
SRI awarded $107 million NIAID-DAIDS contract to provide preclinical services for HIV therapeutics
SRI International has been awarded a contract from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases and the Division of AIDS to support research and product development for human immunodeficiency virus (HIV), Mycobacterium tuberculosis (MTB) complex, and hepatitis B and C viruses (HBV/HCV).
-
SRI International awarded $40 million NICHD contract for pre-clinical development of new male and female contraceptive products
SRI International has been awarded a Biological Testing Facility contract to complete discovery and preclinical development of new contraceptive compounds.
-
SRI International awarded $4.3M from DARPA to create rapid response therapeutic manufacturing system
Extension of SynFini synthetic chemistry platform could accelerate availability ofnew treatments in pandemic and other emergency health situations MENLO PARK, Calif. – October 6, 2020 – SRI International has been awarded $4.3 million from the Defense Advanced Research Projects Agency (DARPA) to create ProSyn™, an agile, rapidly deployable extension of SynFini™, SRI’s fully automated synthetic…
-
Nomura and SRI International create Silicon Valley-based Innovation Center to exclusively service corporate Japan
A funnel for open innovation, experimentation and hands-on experience for Japanese companies MENLO PARK, Calif., PRNewswire, Sept 22, 2020: SRI International has collaborated with Nomura to create the Nomura-SRI Innovation Center (NSIC) – solely dedicated to accelerating the adoption of Silicon Valley’s disruptive technology innovation processes into corporate Japan. NSIC is designed to help Japanese companies…
-
SRI Ventures spin-off Curie AI transforms COVID-19 case management at San Carlos Apache Healthcare Corporation
CurieAI’s innovative tech helps save lives by monitoring patients to predict case improvement vs deterioration.
-
SRI International Awarded Contract Worth Up to $100M from National Institute of Allergy and Infectious Diseases for Radiation/Nuclear Medical Countermeasures
Grant extends SRI’s long history of collaborations with the National Institutes of Health.
-
Almost one third of life science companies set to begin quantum computing evaluation this year
Pistoia Alliance, QED-C and QuPharm join forces to help biopharma and healthcare industry exploit quantum computing’s potential
-
SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence
Companies will combine SynFini and Centaur Chemist platforms to focus on small-molecule oncology target.
-
SRI Ventures Startup Decoded Health Launches Telehealth App Powered by Explainable AI to Meet Demand Surge Amidst COVID-19 Pandemic
New app improves health outcomes and accessibility through its “Virtual Medical Resident” to augment physicians seeking to reach more patients in need with telemedicine. MENLO PARK, CA. APRIL 29, 2020 – SRI Ventures, the corporate venture arm of SRI International, announced the release of Decoded Health’s first telehealth app that uses explainable artificial intelligence technology…
-
The Quantum Economic Development Consortium (QED-C) Releases Survey Showing COVID-19’s Impact on Quantum Businesses
Survey by the consortium managed by SRI International shows one third of respondents taking drastic measures, such as layoffs, within three months if lockdown continues
-
SRI International’s CMOS Imager Aboard the Parker Solar Probe Mission Named Gold Winner of the Edison Awards
Global nonprofit research center recognized for contributions to NASA’s Solar Probe.